ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 161 filers reported holding ARCUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,278 | -25.3% | 516,864 | -15.4% | 0.03% | -26.3% |
| Q2 2023 | $12,413 | -12.2% | 611,172 | -21.1% | 0.04% | -22.4% |
| Q1 2023 | $14,132 | -10.7% | 774,792 | +1.2% | 0.05% | -14.0% |
| Q4 2022 | $15,832 | -99.9% | 765,550 | +23.0% | 0.06% | -10.9% |
| Q3 2022 | $16,286,000 | +15.1% | 622,564 | +11.5% | 0.06% | +18.5% |
| Q2 2022 | $14,155,000 | -43.7% | 558,602 | -29.9% | 0.05% | -37.9% |
| Q1 2022 | $25,156,000 | -27.8% | 797,091 | -7.5% | 0.09% | -25.0% |
| Q4 2021 | $34,857,000 | +27.3% | 861,294 | +9.7% | 0.12% | +13.7% |
| Q3 2021 | $27,377,000 | +219.8% | 785,106 | +151.8% | 0.10% | +229.0% |
| Q2 2021 | $8,562,000 | – | 311,796 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |